Biologic agents in nail psoriasis: efficacy data and considerations.
about
Serum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.Serum levels of TNF- α , IL-12/23 p40, and IL-17 in psoriatic patients with and without nail psoriasis: a cross-sectional study.
P2860
Biologic agents in nail psoriasis: efficacy data and considerations.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biologic agents in nail psoriasis: efficacy data and considerations.
@ast
Biologic agents in nail psoriasis: efficacy data and considerations.
@en
type
label
Biologic agents in nail psoriasis: efficacy data and considerations.
@ast
Biologic agents in nail psoriasis: efficacy data and considerations.
@en
prefLabel
Biologic agents in nail psoriasis: efficacy data and considerations.
@ast
Biologic agents in nail psoriasis: efficacy data and considerations.
@en
P2093
P2860
P1476
Biologic agents in nail psoriasis: efficacy data and considerations.
@en
P2093
Aikaterini Kyriakou
Aikaterini Patsatsi
Dimitrios Sotiriadis
P2860
P304
P356
10.1517/14712598.2013.851192
P407
P577
2013-10-25T00:00:00Z